Patient Reports of Satisfaction after Microvascular Decompression and Partial Sensory Rhizotomy for Trigeminal Neuralgia

Oral Medicine, Barts and the London, Queen Mary's School of Medicine and Dentistry, London, England.
Neurosurgery (Impact Factor: 3.03). 07/2005; 56(6):1304-11; discussion 1311-2. DOI: 10.1227/01.NEU.0000159883.35957.E0
Source: PubMed

ABSTRACT There are no reports of patient satisfaction surveys after either a microvascular decompression (MVD) or a partial sensory rhizotomy (PSR) for trigeminal neuralgia. This study compares patient satisfaction after these two types of posterior fossa surgery for trigeminal neuralgia, because it is postulated that recurrences, complications, and previous surgical experience reduce satisfaction.
All patients who had undergone their first posterior fossa surgery at one center were sent a self-complete questionnaire by an independent physician. Among the 44 questions on four standardized questionnaires were 5 questions that related to patient satisfaction and experience of obtaining care. Patients were divided into those having their first surgical procedure (primary) and those who had had previous ablative surgery (nonprimary).
Response rates were 90% (220 of 245) of MVD and 88% (53 of 60) of PSR patients. Groups were comparable with respect to age, sex, duration of symptoms, mean duration of follow-up, and recurrence rates. Overall satisfaction with their current situation was 89% in MVD and 72% in PSR patients. Unsatisfied with the outcome were 4% of MVD and 20% of PSR patients, and this is a significant difference (P < 0.01). Satisfaction with outcome was higher in those undergoing this as a primary procedure. In the primary group, satisfaction was dependent on recurrence and complication/side effects status (each P < 0.01), but this was not the case in the nonprimary group. Patients expressed a desire for earlier posterior fossa surgery in 73% of MVD and 58% of PSR patients, and this was highest in the primary group. The final outcome was considered to be better than expected in 80% of MVD and 54% of PSR patients, but 22% of the PSR group (P < 0.01) thought they were worse off.
Patients undergoing posterior fossa surgery as a primary procedure are most satisfied and PSR patients are least satisfied, partly because of a higher rate of side effects.

Download full-text


Available from: Joanna M. Zakrzewska, Jul 04, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are few reports on the outcome of surgical treatment of TGN without vascular compression. Between 1984 and 2004, 668 patients underwent MVD for TGN. In 21 patients (3.1%), vascular compression was absent. The surgical strategy in these cases involved the following: (1) dissection and exposure of the entire trigeminal nerve root; (2) slight neurapraxia with bipolar tips at the trigeminal nerve root; and (3) isolation of trigeminal nerve with Teflon sponge fragments. The patients' (female/male, 20:1) ages ranged from 33 to 77 years. Their right side was the most frequently involved (61.9%). Their mean duration of pain before treatment was 7.6 years (range = 1-20 years). At surgical exploration, vascular compression or anatomical abnormalities were absent in 15 patients (71.4%), arachnoidal thickening was present in 5 (23.8%), and fiber dissociation of the trigeminal nerve was present in 1 (4.8%). Mean follow-up after surgery was 17.7 months (range = 4-65 months). Immediate relief from pain occurred in all 21 patients. On Kaplan-Meier analysis, recurrence was maintained at 14.8% for 12, 24, and 36 months, increasing to 43.2% at 48 months. Permanent hypoesthesia was present in 6 patients (28.6%), whereas loss of corneal reflex was observed transiently in 1 (4.8%). Motor function of the trigeminal nerve was intact in all patients. No other complication was found. The proposed surgical plan of standard MVD plus slight trigeminal nerve root neurapraxia is a safe and effective management option for TGN without vascular compression.
    Surgical Neurology 08/2006; 66(1):32-6; discussion 36. DOI:10.1016/j.surneu.2005.10.018 · 1.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Izvleček Izhodišča Namen študije je bil ugotoviti, ali obstaja pomembna razlika v uspešnosti zdravljenja tri- geminusne nevralgije (TN) z mikrovaskularno dekompresijo (MVD) med skupino bolni- kov, starih 65 let ali mlajših, in skupino starejših od 65 let in določiti učinkovitost in var- nost te metode pri starejših bolnikih. Metode 40 bolnikov smo operirali zaradi trdovratne tipične TN in pri vseh naredili MVD trigemi- nusa. Ocenili smo olajšanje bolečine takoj po operaciji in 2 leti po MVD pri 22 bolnikih, starejših od 65 let, in pri 18 bolnikih, mlajših od 65 let. Pri obeh skupinah smo upoštevali še druge dejavnike: trajanje bolečine pred MVD, telesna pripravljenost bolnikov za operaci- jo, vrsta žile (arterija ali vena), ki je povzročila pritisk na trigeminus, trajanje bolnišnične- ga zdravljenja in pooperativne zaplete. Abstract Background The study aimed to determine the possible differences in the effectiveness of microvascular decompression for the treatment of trigeminal neuralgia between patients aged 65 or younger and patients older than 65 years, and to clarify the efficacy and safety of the MVD in elderly patients.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Several issues regarding diagnosis, pharmacological treatment, and surgical treatment of trigeminal neuralgia (TN) are still unsettled. The American Academy of Neurology and the European Federation of Neurological Societies launched a joint Task Force to prepare general guidelines for the management of this condition. After systematic review of the literature the Task Force came to a series of evidence-based recom- mendations. In patients with TN MRI may be considered to identify patients with structural causes. The presence of trigeminal sensory deficits, bilateral involvement, and abnormal trigeminal reflexes should be considered useful to disclose symptomatic TN, whereas younger age of onset, involvement of the first division, unresponsiveness to treatment and abnormal trigeminal evoked potentials are not useful in distin- guishing symptomatic from classic TN. Carbamazepine (stronger evidence) or ox- carbazepine (better tolerability) should be offered as first-line treatment for pain control. For patients with TN refractory to medical therapy early surgical therapy may be considered. Gasserian ganglion percutaneous techniques, gamma knife and microvascular decompression may be considered. Microvascular decompression may be considered over other surgical techniques to provide the longest duration of pain freedom. The role of surgery versus pharmacotherapy in the management of TN in patients with multiple sclerosis remains uncertain.